Female Sexual Arousal Disorder Treatment in Tampa, FL

'Female sexual arousal disorder (FSAD) is a recognized sexual dysfunction characterized by persistent difficulty attaining or maintaining physical arousal during sexual activity, including reduced lubrication, absent engorgement, and limited genital sensation. It is distinct from low libido, though the two often co-occur. FSAD has measurable physiological causes including hormonal imbalances, tissue changes, and vascular factors that can be treated directly.'

'The most common causes include estrogen deficiency from menopause or perimenopause, postpartum hormonal changes during breastfeeding, certain medications (SSRIs, beta-blockers, some hormonal contraceptives), autoimmune conditions affecting pelvic nerve function, and chronic stress-driven hormonal imbalances. In many women, multiple causes are present simultaneously.'

'Yes. When the physiological causes are identified, most women see meaningful improvement with targeted treatment. Hormone replacement therapy, the O-Shot, stem cell therapy, and red light therapy address different components of the arousal response system, and many women benefit from combinations of these approaches.'

'The O-Shot uses platelet-rich plasma to stimulate tissue repair, increased blood flow, and improved sensitivity in vaginal and clitoral tissue. This directly addresses the tissue-level components of arousal difficulty, particularly atrophy and reduced vascularization. Results typically develop over 3 to 6 weeks after treatment as tissue regenerates.'

'For women with FSAD driven by estrogen and testosterone deficiency, hormone replacement is often the most impactful single intervention. Estrogen rebuilds the tissue environment required for lubrication and engorgement; testosterone restores nerve sensitivity. Optimizing both hormones creates the physiological foundation that makes other treatments more effective.'

'Untreated hormonal deficiencies that contribute to FSAD generally progress over time. Vaginal atrophy, reduced tissue sensitivity, and declining blood flow worsen as estrogen levels fall further. Addressing the condition earlier typically produces better outcomes than waiting.'